Famotidine, 20 mg 30 pcs

Famotidine has an antiulcer effect. Blocker of H2-histamine receptors of III generation. Suppresses basal and stimulated by histamine, gastrin and acetylcholine production of hydrochloric acid. Reduces the activity of pepsin.

It enhances the protective mechanisms of the gastric mucosa, promotes healing of lesions associated with the impact of hydrochloric acid (including scarring of stress ulcers) and cessation of gastrointestinal bleeding by increasing the formation of gastric mucus, its glycoprotein content, stimulation of secretion of hydrocarbonate by the gastric mucosa, endogenous synthesis of prostaglandins in it and the rate of regeneration. It does not significantly change the level of gastrin in plasma.

It weakly inhibits cytochrome P450 oxidase system in the liver.

After oral administration the action begins after 1 hour, reaches a maximum within 3 hours. The duration of action of the drug in a single dose depends on the dose and varies from 12 to 24 hours.

Indications

Acid reflux, Heartburn, Reflux esophagitis, Gastroduodenitis, Peptic ulcer, Pain in the epigastric region, Gastritis

• Gastric and duodenal ulcer (including prevention of exacerbations.
• symptomatic ulcers, erosive and reflux esophagitis;
• Zollinger-Ellison syndrome.

.

Active ingredient

Famotidine

Composition

1 tablet contains:

The active ingredient:

Famotidine 20 mg;

Associates:

Corn starch,

Microcrystalline cellulose,

Silicon dioxide, <

talc,

magnesium stearate,

sodium croscarmellose;

Composition of the shell:

Hypromellose, macrogol 6000, titanium dioxide (E171), talc, iron oxide brown dye.